Covered recipient · General Payments record
ZACHARY TRAVIS WARD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$880.07
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $565.48 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $290.73 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $108.71 | 2 |
| EISAI INC. | $102.50 | 1 |
| TG THERAPEUTICS, INC. | $22.72 | 1 |
| SK Life Science, Inc. | $22.17 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $18.65 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093967245 | CMS |
| Biogen, Inc. | $19.86 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104874042 | CMS |
| Biogen, Inc. | $24.84 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104848962 | CMS |
| Biogen, Inc. | $11.11 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104847246 | CMS |
| Biogen, Inc. | $96.73 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104856872 | CMS |
| Biogen, Inc. | $138.19 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104862726 | CMS |
| Eisai Inc. | $102.50 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110790114 | CMS |
| Novartis Pharmaceuticals Corporation | $87.66 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087427028 | CMS |
| Novartis Pharmaceuticals Corporation | $21.05 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087427030 | CMS |
| SK Life Science, Inc. | $22.17 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154114577 | CMS |
| TG Therapeutics, Inc. | $22.72 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136870981 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.